Movatterモバイル変換


[0]ホーム

URL:


US3877843A - Pulsatile pumping system - Google Patents

Pulsatile pumping system
Download PDF

Info

Publication number
US3877843A
US3877843AUS361960AUS36196073AUS3877843AUS 3877843 AUS3877843 AUS 3877843AUS 361960 AUS361960 AUS 361960AUS 36196073 AUS36196073 AUS 36196073AUS 3877843 AUS3877843 AUS 3877843A
Authority
US
United States
Prior art keywords
control
pressure
pump
fluid
perfusate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US361960A
Inventor
Halbert Fischel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories IncfiledCriticalBaxter Laboratories Inc
Priority to US361960ApriorityCriticalpatent/US3877843A/en
Application grantedgrantedCritical
Publication of US3877843ApublicationCriticalpatent/US3877843A/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

A portable pulsatile pumping system simulates the pumping mechanism of a human heart in pumping fluid for such applications as organ perfusion systems. The pumping system includes a regulated source of pressurized gas, a pulsatile pump having an aorta chamber providing a sustained minimum diastolic pressure and a ventricle chamber providing a higher systolic pressure during a selectively variable part (1 to 99 percent) of each cyclic pumping action, the periodicity of which may be varied from 5 to 150 cycles per minute. The gas source is connected to the pump by a first adjustable pressure regulator to maintain the chosen diastolic pressure in the aorta chamber. The ventricle chamber is alternately coupled to gas pressure taken through a second pressure regulator and vented by a solenoid mechanism operated by a digital electronic timing control circuit. The digital electronic control system employs digital counters and selector switches to generate square wave pulses of varying duration and periodicity in a manner which provides both conservation of electrical battery energy and high reliability. At the same time, an optimum pumping system is achieved because the elasticity of the gas and connecting tubing are employed to smooth the sharp signal transitions.

Description

United States Patent [191 Fischel 1451 Apr. 15, 1975 1 PULSATILE PUMPING SYSTEM [75] Inventor: Halbert Fischel, Sherman Oaks,
Calif.
[73] Assignee: Baxter Laboratories, Inc., Morton Grove, Ill.
22 Filed: May 21,1973
21 Appl. No.: 361,960
[56] References Cited UNITED STATES PATENTS 3,266,487 8/1966 Watkins et al 128/1 D 3,376,660 4/1968 McGinnis 128/1 D X 3,430,624 3/1969 Flanagan et a1.
3,516,331 6/1970 Oelrich et al. 91/459 X 3,545,221 12/1970 Swenson et al. 195/127 X 3,639,084 2/1972 Goldhaber 417/394 Primary ExaminerWilliam L. Freeh Assistant Examiner-Richard E. Gluck Attorney, Agent, or F irm-Garrettson Ellis [57] ABSTRACT A portable pulsatile pumping system simulates the pumping mechanism of a human heart in pumping fluid for such applications as organ perfusion systems. The pumping system includes a regulated source of pressurized gas, a pulsatile pump having an aorta chamber providing a sustained minimum diastolic pressure and a ventricle chamber providing a higher systolic pressure during a selectively variable part (1 to 99 percent) of each cyclic pumping action, the periodicity of which may be varied from 5 to 150 cycles per minute. The gas source is connected to the pump by a first adjustable pressure regulator to maintain the chosen diastolic pressure in the aorta chamber. The ventricle chamber is alternately coupled to gas pressure taken through a second pressure regulator and vented by a solenoid mechanism operated by a digital electronic timing control circuit. The digital electronic control system employs digital counters and selector switches to generate square wave pulses of varying duration and periodicity in a manner which provides both conservation of electrical battery energy and high reliability. At the same time, an optimum pumping system is achieved because the elasticity of the gas and connecting tubing are employed to smooth the sharp signal transitions.
10 Claims, 4 Drawing Figures II:- 140/80 m2 PERFUSION i SYSTEM H Uw M-L ,2 l-T'fli' l PATENTEBAPR 1 51975sum 1 95 3 TEMPERATURE CONTROL SYSTEM FROM CONTROL CIRCUIT 86 1 PRESSURIZEO AIR CONTROL CIRCUIT T0 SYSTEM No.2
P,-' .TENTEBAPR1 SL975 877. 843sum 3 5 3 30a 220 o 2.2m i
ONESHOT 306 2K IOOO/l/u -soo 90 f:
FlG.-4
PULSATILE PUMPING SYSTEM BACKGROUND OF THEINVENTION 1. Field of the Invention This invention relates to a system providing gentle, pulsatile pumping for life sustaining fluids, and more particularly to pulsatile pumping systems for organ perfusion systems whose cyclic characteristics may be varied within wide ranges.
2. History of the Prior-Art There are many biomedical systems in which it is desirable to pump life sustaining fluids in a pulsatile manner closely simulating cardiac action. One such application is in an organ perfusion system for preserving an organ such as a kidney from the time it is removed from a donor until it is feasible to transplant it in a recipient.
An organ perfusion system typically recirculates a perfusate containing oxygen and nutrients under control of a pump. Perfusate is drawn from a pool in which the kidney rests, passed through an oxygenator which adds oxygen and removes carbon dioxide, adjusted in temperature, typically by cooling to 510 C., and returned to the kidney. Incoming perfusate is connected to the renal artery of the kidney and passes through the kidney to the pool of perfusate in which the kidney rests, from which pool it is again recirculated. While the reasons are not fully understood at present, a pulsatile pumping action is preferred because it appears to aid the distribution of perfusate through an organ and the performance of life sustaining functions.
Because of the difficulty of getting donors and recipients at the same place at the same time it is desirable that an organ perfusion system be portable and be able to maintain the organ viable, for at least several days. At the same time it must provide smooth, gentle handling of the perfusate under controlled conditions so as not to shock the life sustaining fluid. An advantageous pulsatile pump that closely simulates cardiac pumping action when properly energized is described in U.S. Pat. No. 3,639,084 and incorporates distensible ventricle and aorta chambers connected in series by one-way valves. An atrium chamber collects perfusate under gravity flow and the adjacent ventricle chamber responds to applied periodic systolic pressures to pump perfusate into the aorta chamber which is under constant bias to provide a sustained minimum diastolic pressure. As described in the referenced patent. the systolic and diastolic pressures may be supplied by a regulated source of pressurized air and a fluid logic control circuit may control the periodic repetition of systolic pressure in the ventricle chamber. However, the fluid timing and logic control requires large amounts of compressed air, which militates against portability, and such controls do not adequately permit adjustability over wide operat on ranges.
SUMMARY OF THE INVENTION A pulsatile pumping system for life sustaining fluids in accordance with the invention is portable and economical but yet provides the high reliability, versatility and gentle handling needed for organ perfusion. A pulsatile pump is driven by a highly portable pressurized gas source under control of an accurate, low energy digital electronic circuit. The digital circuit provides accurate control of the pumping action over a wide range of pumping rates and pressure proportions while LII the elasticity of the gas and connecting tubing smooth sharp transitions resulting from digital control.
A particular example of the system includes a pump of the distensible chamber type having ventricle and aorta chambers responsive to applied fluid pressures, a source of pressurized fluid providing driving energy for the pump, a diastolic pressure regulator valve coupling the pressurized fluid to the aorta chamber to maintain a constant diastolic pressure therein, a systolic pressure regulator valve coupling the pressurized fluid to the ventricle chamber to provide alternate atmospheric and systolic pressures therein under control of an electronic control circuit, and an electronic digital control circuit connected to control the systolic pressure regulator valve. The control circuit includes a transducer which is responsive to square wave signals and a digital circuit providing square wave signals at a selected variable frequency with the systolic portion of each cycle having a selectively variable proportion. The elasticity of the driving fluid and connecting conduits smooth the sharp actuating signal transitions provided by the digital electronic control to attain a gentle but precise pumping action.
The control circuit includes a variable frequency square wave clock signal generator and two series connected stages of a binary coded decimal (BCD) counter which recycles after each cycles of the clock signal. BCD to decimal decoders are connected to provide a decimal output indicating the state of the units and tens portions of the counter respectively. A pair of two rotor multiple contact rotary switches is connected to the decimal outputs of each of the units and tens decoders so that the rotatable wiper arms are energized when the counters have counted to the decimal outputs which are connected to the contacts at which the rotors are set. A flip flop providing the systolic pressure control signal is connected to reset when the counters recycle and set when the advancing count causes the rotors of both the units and tens switches to become simultaneously activated. As the flip flop sets and resets it provides a square wave pump control signal demarcating alternate diastolic and systolic time intervals withadjustably selectable proportions and the frequency.
BRIEF DESCRIPTION OF THE DRAWINGS A better understanding of the invention may be had from a consideration of the following detailed description taken in conjunction with the accompanying drawings in which:
FIG. 1 is a schematic diagram of an organ perfusion system utilizing a pulsatile pumping system in accordance with the invention;
FIG. 2 is a partly block diagram and partly schematic representation of a digital electronic control circuit controlling the operation of the pulsatile pumping system shown in FIG. 1;
FIG. 3 is a schematic diagram representation of a variable frequency square wave clock signal generator used in the electronic control circuit shown in FIG. 2; and
FIG. 4 is a schematic diagram representation of a square wave clock signal frequency indicator used in the electronic control circuit shown in FIG. 2.
DETAILED DESCRIPTION Referring to FIG. 1, there is shown a portable organ perfusion system for preserving living organs over an extended period of time. Thesystem 10 includes a container ororgan chamber 12, in which an organ is to be maintained, aperfusate conditioning system 14 and a pulsatile pumping system 16 which controls the recirculation of life substaining perfusate from a pool in thecontainer 12, through theconditioning system 14 and through anorgan 18 in thecontainer 12 back to the pool in thecontainer 12.
Perfusate moves under gravity flow from the pool in thecontainer 12 through aconduit 20 andT section 22 to anoxygenator 24 of conventional construction. TheT section 22 contains athermistor probe 26 which is in thermal communication with perfusate passing therethrough and generates an electrical temperature signal indicative of perfusate temperature on aconductor 28. Perfusate enters the oxygenator at aninlet 30 and passes through theoxygenator 24 under gravity flow to anoutlet 32. Theoxygenator 24 has anoxygen inlet 34 connected by aconduit 36 to apressure regulating valve 38 which is in turn connected to a source of pressurizedoxygen 40. Thepressure regulator valve 38 maintains the oxygen pressure within theoxygenator 24 at a proper level for dissolving a desired amount of oxygen in the perfusate as it passes through theoxygenator 24. An outlet42 is connected to aconduit 44 to vent carbon dioxide which is removed from the perfusate as it passes through the oxygenator. Thus, as perfusate reaches theoutlet 32 it has been resupplied with oxygen and unwanted carbon dioxide has been removed. Anaccess T coupling 46 is connected byconduits 48 and 50 between theoutlet 32 of theoxygenator 24 and aninlet 52 of apulsatile pump 54 within the pumping system 16.
Thepump 54, which is of the distensible chamber type described in US. Pat. No. 3,639,084, delivers the perfusate at anoutlet 56 from which it passes through aconduit 58 to aheat exchanger 60 havingperfusate inlet 62 connected to theconduit 58 and aperfusate outlet 64. Theheat exchanger 60 has aninlet 66 andoutlet 68 through which a heat carrying fluid passesto provide thermal compensation for the perfusate to tend to maintain it at a selected constant temperature. Atemperature control system 70 receives the heat carrying fluid through aconduit 72 which is connected to theoutlet 68 and delivers heat carrying fluid through aconduit 74 to theinlet 66.
Thetemperature control system 70 is connected to operate in response to the temperature control signal onconductor 28 to maintain the perfusate at a desired temperature. The temperature control system removes heat from the heat carrying fluid as it is recirculated through theheat exchanger 60 in a typical situation where a perfusate temperature of 5l0 C. is desired. As the heat carrying fluid is circulated through theheat exchanger 60 it is in thermal communication with-the perfusate, thereby tending to maintain perfusate leaving the heat exchanger atoutlet 64 at the same temperature as heat carrying fluid entering the heat exchanger throughinlet 66. In other arrangements it may be desirable to maintain the perfusate at or near normal body temperature control and in this case it may be necessary for thetemperature control system 70 to add heat to the heat carrying fluid as it is recirculated through theheat exchanger 60 in order to maintain the perfusate at the desired temperature.
As perfusate leaves theoutlet 64 ofheat exchanger 60 it flows throughconduit 76 to access T coupling 78 I and then throughconduit 80 back to thecontainer 12 where theconduit 80 is connected to anorgan 18 which is being preserved. For instance in the case of a kidney, theconduit 80 would be connected to the renal artery thereof. Theaccess T couplings 46 and'78 permitperfusate to be periodically. drawn off by hypoder- A mic needles for laboratory analysis. Similarly, substances can be added to the perfusate by injection through theaccess T couplings 48, 78.
In addition to thepump 54, the pumping system. 16
thepump 54, a solenoid transducer 84 controlling a systolic pressure valve in the pressure regulating and conduit system and a digitalelectronic control system 86 providing a periodic square wave pulse control signal for actuating solenoid 84. The source of pressurized fluid may alternatively be provided by a battery driven electric motor driving a compressor. The pulse control signal has a selectively variable frequency with systolic and diastolic time intervals of adjustably selectable duration within each cycle. The pump '54 is designed to provide a gentle pulsatile pumping action closely resembling the pumping action of a human heart which alternates a relatively low diastolic pressure with a relatively high systolic pressure during each pumping cycle. Thepump 54 contains three chambers which are con nected in series through one-way valves 88 and 94 which permit perfusate to flow only in a forward direction through thepump 54. Anatrium chamber 92 co]- lects perfusate as it passes under gravity flow through.
theinlet 52. A ventricle chamber is divided by aflexible membrane 96 intotwo portions. An interior orperfusate portion 98 ofthe ventricle chamber is interior to themembrane 96 and receives perfusate throughoneway valve 88 from theatrium 92 under gravity flow when the external ordriving fluid portion 100 of the ventricle is at atmospheric pressure. The external por tion 100 of the ventricle chamber is connected to the pressure regulating system through a small flexible, elastically expansible energy absorbing conduit 102 of a resilient material such as silicone rubber having an.
inside diameter of about A inch.
The pressure regulating system includes a high pressure regulating valve having aninlet orifice 112 connected to thehigh pressure source 82 and anoutlet orifice 114. Thepressure regulating valve 110 maintains a constant pressure of about 20 psi at theoutlet 114.A Y connection 116 has an inlet connected to theregulated pressure outlet 114 andseparate outlets 120, I22. A fourway diastolicpressure regulator valve 124 has aninlet orifice 126 connected tooutlet 120, anoutlet oriflce 128 and avent orifice 130. The diastolicpressure regulator valve 124 provides a selectable constant output pressure of 0-500 millimeters of mercury at theoutlet 128. This diastolic pressure is set at a desired level by varying the position of acontrol knob 132 which is typically set to provide a diastolic pressure of about 80 millimeters of mercury. Thevalve 124 can either supply theoutlet 128 with driving fluid from.
source 82 or vent driving fluid from theoutlet 128 to the atmosphere throughvent 130 as necessary to maintain the diastolic pressure constant.
Asystolic pressure regulator 136 similar todiastolic pressure regulator 124 has aninlet 137 connected to theoutlet 122 ofY connector 116, anoutlet 138, and avent 139. A four-way valve 140 has aninlet orifice 141 coupled tooutlet 138, anoutlet orifice 142, anatmospheric vent orifice 143 and is mechanically coupled to solenoid 84 to connect theoutlet 142 to atmospheric pressure throughvent 143 when solenoid 84 is inactive and to provide a desired systolic pressure atoutlet 142 when solenoid 84 is activated. A desired systolic pressure between 0 and 500 millimeters of mercury may be selected by rotating acontrol knob 144 oncontrol valve 136 to a desired position. Thecontrol knob 144 is typically set to provide a systolic pressure of 240 millimeters of mercury. The conduit 102 is connected to the regulating system at theoutlet 142 of solenoid actuatedvalve 140.
Anoptional aorta chamber 148 ofpump 54 provides a low diastolic pressure which may be greater than atmospheric pressure and has a construction very similar to that of the ventricle chamber. Theaorta chamber 148 has a flexible membrane ordiaphragm 150 which divides an interior portion of thechamber 152 from anexterior portion 154. Theexterior portion 154 is connected by aconduit 156 to theoutlet 128 of diastolicpressure regulator valve 124 which causes the predetermined diastolic pressure to be constantly maintained in theexternal portion 154 ofaorta chamber 148.
During a diastolic portion ofa pumping cycle, the solenoid 84 is inactive and the external portion 100 of ventricle chamber is vented to atmospheric pressure. This allowsmembrane 96 to expand as perfusate flows by reason of a gravity head through one-way valves 88 from theatrium 92 into theinterior portion 98 of ventricle chamber. Then, as solenoid 84 receives an activating signal fromcontrol circuits 86,systolic control valve 140 is driven to a systolic pressure condition to provide the systolic pressure throughoutlet 142 and conduit 102 to the exterior 100 of ventricle chamber. This relatively high systolic pressure drives perfusate from theinterior portion 98 of ventricle chamber through one-way valve 94 to theaorta chamber 148 which is somewhat smaller than ventricle chamber. As perfusate is forced through one-way valve 94 during this systolic portion of the cycle, theflexible membrane 96 collapses, theinterior portion 98 decreases in volume, and the exterior portion 100 increases in volume. At the beginning of a systole portion of a pumping cycle, thepump 54 continues to provide perfusate at the diastole pressure. However, theaorta membrane 150 rapidly expands to maximum capacity, permitting the systolic pressure to then be passed through the aorta chamber to thekidney 18. The cycle is then repeated as the solenoid 84 is deactivated, causingsystolic control valve 140 to again vent the exterior portion 100 of ventricle chamber to the atmosphere.
After the systolic portion of a pumping cycle is terminated bycontrol circuit 86 themembrane 150 begins to collapse under the constant pressure in theexternal portion 154 of theaorta chamber 148 to force perfusate out through theoutlet 56 at the constant, sustained, minimum diastolic pressure. Before themembrane 150 is completely collapsed a new systolic portion of a pumping cycle must be commenced to force more fluid into the aorta chamber. In this way thepulsatile pump 54 provides alternating diastolic and systolic pressures at theoutlet 56 with a pumping characteristic very closely following that of a human heart The small internal diameter of conduit 102 and the elastic energy absorbing properties of the driving fluid and conduit 102 combine to provide an energy absorbing fluid impedance which acts as a hydraulic filter to smooth sharp pressure transitions in the ventricle chamber. Some life sustaining fluids such as whole blood are easily damaged by shock and must therefore be treated extremely smoothly and gently. This hydraulic impedance or filtering characteristic permits the hydraulic control system to be controlled by a square wave pulse signal having sharp transitions (for example 5 millisecond rise 30 millisecond decay) without damaging the life sustaining fluid. By the time the digital pulse control signals reach the external portion of the ventricle chamber sharp transitions have been filtered out. Thus, thepulsatile pump 54 is able to handle a life sustaining fluid gently and without shock, whether it be whole blood, perfusate or some other fluid, even though control is provided by a digital electronic signal having sharp transitions.
A second organ perfusion system represented by ahollow rectangle 162 and labeled Perfusion System No. 2 is connected to receive perfusate at aninlet 164 through aconduit 166 from the pool incontainer 12 and provide perfusate through outlet 168 andconduit 170 to aconduit 172 which connects to a second organ to be preserved within thecontainer 12. Organ Perfusion System No. 2 shares thecontainer 12 and certain components in thecontrol circuit 82 with Perfusion System No. 1 and may be assumed to be substantially identical to Perfusion System No. 1 even though it is not described in detail.
The electronicdigital control circuit 86 includes a variable frequencysquare wave generator 200 which generates a digital square wave clock signal at a frequency selected by an operator, afrequency indicator circuit 202 which indicates to an operator the frequency of the square wave clock signal, aproportioning control circuit 204, agated flip flop 206, apower amplifier 208 and asolenoid coil 210 which controls the activation of solenoid 84 (FIG. 1).
Theproportion control circuit 204 includes a century counter having a BCD units counter 212, a BCD tens counter 214 connected to count cycles of the counter 21.2, a BCD todecimal converter 216 responsive to the outputs from theunit counter 212 and a BCD todecimal converter 218 responsive to outputs from the BCD tens counter 214. The BCD counters 212, 214 may be implemented with MC 7490P integrated circuits manufactured by Motorola and the BCD todecimal converters 216, 218 may be implemented with MC 7442P integrated circuits, also manufactured by Motorola. The decoded decimal units and decimal tens outputs of the century counter indicate the successive counts of the century counter as it counts clock pulses from 0 to 99 and then recycles back to 0 at count 100. For instance when the counter reaches the count of 55 thenumber 5 outputs of both theunits converter 216 andtens converter 218 will have a high voltage thereat and each of the other decoded decimal outputs will have a low or ground potential thereat. Thecounter 212 and converter216 together with thecounter 214 andconverter 218 form first and second decade counting systems providing discrete decimal outputs indicative of instantaneous counts therein.
Four switches are provided to permit operator control of the proportion of each pumping cycle during which systolic pressure is desired, two for systemNo. 1 and two for system No. 2. Each switch contains two completely insulated portions designated part A and part B having mechanically coupled rotors which are simultaneously and synchronously positioned by a single control knob. Switch U1 is a ten position rotary switch in which an A portion has the fixed contacts thereof connected to the ten decimal outputs of theunits converter 216 in sequence. Similarly, switch T1 is a 11 position rotary switch having ten of its ll contacts connected to the ten decimal outputs oftens converter 218 in sequence. The eleventh contact is not connected. The two switches U2 and T2 of the second perfusion system are connected in similar manner with the ten A contacts of switch U2 connected to the ten decimal outputs ofunits converter 216 and ten of the eleven A contacts of switch T2 connected to the ten decimal outputs oftens converter 218 with the elev' enth A contact left open. The BCD units counter 212 receives the variable frequency clock signal as an input onconductor 220 and BCD tens counter 214 receives its counting input from decimal output zero fromunits converter 216 onconductor 222. Theintegrated circuits 212, 214, 216 and 218 may otherwise be connected, biased and compensated in a conventional manner. Anisolator 224 which may be implemented with an MC 836P integrated circuit manufactured by Motorola is connected to receive inputs from the decimal zero output oftens converter 218, the decimal zero output ofunits converter 216, therotary wiper contact 226 of switch TIA, therotary wiper contact 227 of switch UlA, therotary wiper contact 228 of switch TZA and therotary wiper contact 229 of switch U2A and provide outputs designated OT, OU, TlAR, UlAR. T2, AR, and U2AR respectively in response thereto.
These six signals are used by systolic pulse generating circuits for both systems No. l and No. 2 to generate the systolic pulse signals which actually control the activation ofsolenoid coil 110. Since this portion of the system is identical for both system No. l and system No. 2, the systolic pulse generating circuits for system No. 2 is indicated merely by ahollow rectangle 132 and it will be understood that the same description applies as given hereafter for system No. 1.
As illustrated with respect to system No. 1, the wiper arm signals TLAR and ULAR for the digitand for the decimal and unit switches respectively are received by an ANDgate 234 controlling the .1 input to aJK flip flop 236 within an integrated circuit gatedflip flop 216. The TLAR and ULAR signals operate in combination with the clock signal to activate ANDgate 234 at the selected variable count, causing ANDgate 234 to generate an intermediate control signal which activates the .1 input to flipflop 236. An ANDgate 238 generates an intermediate control signal which activates the K input to flipflop 236 in response to the OT, OU and clock signals which occur as the century counter resets. The ANDgates 234 and 238 are connected to be enabled by the clock signal from thesquare wave generator 200. An inverting preset input to flipflop 236 is connected through a 10K resistor 240 to a 5 volt source. It is also connected to the number contact of the B portion of switch TL. Thenumber 10 contact of the A portion of switch TL is not implemented. A movable ode ofdiode 262 connected to the same +12volt rotor 244 of switch TLB is connected to ground. An inverting clear input to flipflop 236 is connected through a 10 K resistor 242 to a 5 volt source and to thenumber 0 contact of the B portion of the switch UL. The wiper I arm 245 of switch ULB is connected to thenumber 0 fixed contact of switch TLB. Thus, whenever both of the system No. 1 proportioning system switches are set to zero,flip flop 236 is constrained to the clear state.
Similarly, whenever switch TLB is set to the number 10 a position,flipflop 236 is constrained to remain in the one or true state. The Q output offlip flop 236 provides the square wave systolic pulse control signal on con-.ductor 250 which drives thecoil 210 throughpower switching amplifier 208.
Conductor 250 is connected through a 3.3K resistor 252 to the base of annpn transistor 254. The collector oftransistor 254 is connected through a 220 ohm resistor 256 to a +5 volt source and the emitter oftransistor 254 is connected through a 1K resistor 258 to ground and also to the base input of annpn transistor 260. The
emitter oftransistor 260 is connected to ground and the collector is connected both to the anode of adiode 262 and to a negative terminal ofsolenoid coil 210 in solenoid 84. Thesolenoid coil 210 anddiode 262 are connected in parallel with the positive terminal ofcoil 210 being connected to a +12 volt source and the cathsource.
Thepower switching amplifier 208 responds to a systolic pulse control signal onconductor 250 by activating thecoil 210 when the control signal is high or true and inactivating thecoil 210 when the control signal is at ground potential or false. Whenever the systolic pulse, control signal is true,transistor 254 is turned on permitting current to flow through the collector and emitter thereof to inturn cause transistor 260 to be turned on. Astransistor 260 is turned on activating current is permitted to flow from the +12 voltsource throughcoil 210 to the collector oftransistor 260 and then out through the emitter oftransistor 260 to ground. This activation ofcoil 210 causes solenoid 84 to switch four-waypressure regulator valve 136 to the systolic pressure state wherein systolic pressure is applied to external cavity 100. As the systolic pulse control signal returns to ground potential,transistors 254 and 260 are switched off and the continued flow of cur rent through thecoil 210 is blocked. Ascoil 210 is deactivated solenoid 84 causespressure regulator valve 136 to return to a state wherein atmospheric pressure is communicated to external chamber portion 100. En-
ergy which may be stored bysolenoid coil 210 at thetime transistor 260 is switched off may be dissipated throughdiode 262.
The variable frequencysquare wave generator 200 is illustrated in greater detail in FIG. 3. The generator.
200 includes a type 2N284Ovariable frequency oscillator 260 having a B2 terminal connected througha l K resistor 262 to a +5 volt source and a BL terminal connected through a 68ohm resistor 264 to ground. The
control terminal E ofoscillator 260 is connected through a 15p. farad capacitor 266 to ground and also through afrequency control circuit 268 to the +5 volt source. Thefrequency control circuit 268 includes a 20K potentiometer 270 having one terminal and the wiper contact connected to the +5 volt source and the other terminal connected to a 16.5K resistor 272. The other terminal ofresistor 272 is connected to one terminal of an 8.2megohm resistor 274 and one terminal of a 1megohm potentiometer 276 having a logarithmically varying resistance. The opposite terminal ofresistor 274, the wiper arm ofpotentiometer 276, and the opposite terminal ofpotentiometer 276 are connected to the gate or control input E tooscillator 260. The output from theoscillator 260 is taken from a BL terminal which is connected througha l K resistor 280 to the base of annpn amplifying transistor 282.Transistor 282 has its emitter connected to ground and its collector connected through a 3.3K resistor 284 to a +5 volt potential. The collector oftransistor 282 is connected to the base of asecond amplifying transistor 286 having its emitter connected to ground and its collector connected through a 1K resistor 288 to the +5 volt potential, The square wave clock signal is provided onconductor 220 which is connected to the collector of amplifyingtransistor 286.
The variablesquare wave generator 200 provides a square wave clock signal at a frequency variable between 8.33 and 250 hertzin accordance with the setting ofpotentiometer 276. This frequency range corresponds to a frequency range of 500 to 15,000 cycles per minute which is divided by 100 by thecentury counter 204 to provide a frequency range of 5 to 150 pulses per minute for the systolic pulse control signal onconductor 250.
Thefrequency indicator circuit 202 is illustrated in greater detail in FIG. 4. Thefrequency indicator 202 includes a oneshot 300 which receives the clock signal fromsquare wave generator 200 onconductor 220 and generates a positive output for a selected time interval in response to each positive going transition of the clock input. The one shot 300 may be a type MC 8601? integrated circuit manufactured by Motorola and has a 44.2K resistor 302 and a 0.22 p. farad capacitor 304 connected in a conventional manner to control the time interval of the output. The output is taken from the key terminal and connected through a 2.21K resistor 306 and a 2 Ktrim pot 308 to a positive terminal of amilliameter 310 which has its negative terminal connected to ground. A 90 ,u.farad filter capacitor 312 is connected in shunt across the terminals ofmilliameter 310 to smooth changes in voltage across the terminals of themeter 310. Theresistor 306 andpotentiometer 308 operate in conjunction with a fixed voltage at the Q output of one shot 300 to provide in effect a constant current source which providesmeter 310 with a fixed amount of charge for each fixed firing interval of oneshot 300. The total charge per unit oftime reaching milliameter 310 is thus directly proportional to the frequency at which the one shot is fired under control of clock signal onconductor 220. This charge must pass throughmilliameter 310 in the form of a current which drives the pointer to a rotational position directly proportional to the frequency of the clock signal.Milliameter 310 may be calibrated to indicate the frequency of the systolic pulse control signal directly.
The electronicdigital control circuit 86 provides precise, highly reliable, low cost control of the pulsatile pumping system with the consumption of very little electrical power. A highly portable, conventional 12 volt battery (not shown) easily provides the required source of electrical energy. A conventional voltage regulator such as a LM309K manufactured by National Semiconductor may be connected to the 12 volt battery to provide the +5 voltage source required at many points in thecontrol circuit 86. While an easily portable battery provides the electrical power, an easily portable bottle of pressurized air may be used to provide the pneumatic power. Since the pressurized air driving fluid is used only to drive thepulsatile pump 54, much less driving fluid is consumed by theperfusion system 10 than would be required if the driving fluid were also used to energize a pneumatic timing control system. Since a 25-pound bottle of pressurized air will operate theperfusion system 10 for 8-12 hours, the complete perfusion system including energy sources is relatively light in weight and highly portable. This arrangement makes optimum use of both electrical and pneumatic elements and energy sources to provide an economical, highly reliable,portable perfusion system 10 which can be used to preserve an organ for several days while transporting it from one place to another.
The electrical control system permits the systolic portion of each cycle of thepulsatile pump 54 to be varied under automatic control between 1 and 99 percent, fixed at 0 percent, fixed at percent or completely controlled by hand. For instance, by setting the units and tens control switches to number 55, diastolic pressure will be provided during the first 55 percent of each pumping cycle and systolic pressure will be provided during the last 45 percent of each pumping cycle. As the century counter recycles the 0 outputs of both the units and tens BCD todecimal converters 216, 218 will go true causing the OT and OU signals to go true to activate the K input to flipflop 236. The K input causesflip flop 236 to reset and produce a ground potential output signal which turns offpower amplifier 208 to deactivatesolenoid coil 210 and connect the exterior portion 100 ofventricle chamber 94 to atmospheric pressure. As soon as the century counter reaches the count of 55 the 5" outputs of the units and tens BCD todecimal converters 216, 218 go true causing the TLAR and ULAR signals to go true, thereby activating the J input to flipflop 236. As the J input is activatedflip flop 236 switches to the true state to provide a high voltage systolic signal which turns onpower switching amplifier 208 to activate thecoil 210 in solenoid 84 and connect the external portion 100 of ventricle chamber to the selected systolic pressure. This systolic pressure is maintained throughout the last 45 counts of the pumping cycle until thecentury counter 204 recycles to again switch the systolic pulse control signal to the low state. By setting the proportion switches TL and UL at any desired count between 99 and 1 the systolic or high pressure portion of each pumping cycle can be varied from 1 to 99 percent.
When both the units and tens proportioning switches are set to the zero position, the B portion of the switch causesflip flop 236 to be constrained to the zero state and the exterior portion 100 of ventricle chamber is continuously vented to atmospheric pressure. Similarly, when the tens switch is set to thenumber 10 position the preset input offlip flop 236 is continuously activated causing the flip flop to provide a continuous systole signal as a pulse control signal to cause a systole pressure to be continuously provided to the exterior portion 100 of ventricle chamber. Sincepulsatile pump 54 requires alternating systolic and atmospheric pressures in the ventricle chamber to maintain pumping action, no fluid will be pumped so long as the proportion switches are set to provide continuous systolic or diastolic pressures at the ventricle chamber. However, by
setting the tens unit switch in the zero position and manually alternating the ten switch between the zero and ten position, both the frequency of the pumping cycle and the relative proportions of systolic and dia stolic pressure can be controlled manually over any desired range.
Although there has been described above a particular arrangement of a pulsatile pumping system in accordance with the invention, it will be appreciated that the scope of the invention is not limited thereto. Accordl ingly, any modification, variation or equivalent arrangement within the scope of the appended claims should be considered to be within the scope of the invention.
What is claimed is:
l. A system for providing a selectively controllable pulsatile flow of a perfusate to simulate cardiac action comprising: a pulsatile perfusate pump which comprises flexible chamber means, said means being collapsible in response to applied fluid pressure, to pump perfusate in said chamber means through a flow line in pulsatile manner;
at least one fluid pressure means;
adjustable systolic pressure regulator means coupled to said fluid pressure means;
first conduit means including control signal respon sive valving means coupling said systolic pressure regulator means to said ventricle chamber means; and
electronic control means including adjustable means for generating square wave control signals of adjustable duration and repetition rate, the square waves having sharp rise and fall times, wherein said valving means comprises a two output valve having a venting output and an output communicating with said perfusate pump, wherein said fluid pressure means comprises a pressure storage vessel, and wherein said electronic control means comprises counter means adjustable to provide valving means controlling outputs at selected counts, said I counter means being adapted to count said square wave control signals.
2. The invention as set forth inclaim 1 above, wherein said first and second conduit means comprise small diameter resilient tubing, and wherein the applied fluid under pressure is air.
3. A combination electronic pneumatic pump control system for gently controlling a pulsatile pump maintaining a first output pressure and producing a periodically occurring systolic output pressure greater than the first pressure in response to a periodically occurring fluid drive pressure comprising:
a selectively venting pressure control valve having an input connectable to a drive fluid pressure source under control of a transducer;
a conduit connected to the outlet of the pressure control valve to a fluid operated pulsatile pump for providing operating fluid to said pump, said conduit restricting the flow of drive fluid therethrough;
a transducer connected to control said pressure control valve to selectively connect the outlet to said pressure source in response to first and second states respectively of an electronic digital control signal having sharp transitions between states; and
an electronic digital control circuit providing an electronic digital control signal to the transducer, said control circuit including a recycling counter,
means responsive to the counter for switching the electronic digital control signal to a first state when the counter reaches a first selected count, and means for switching the electronic digital control signal to a second state when the counterreaches a second selected count, each state being present during a selected variable proportion of each control signal.
4. The pump control system asset forthin claim 3 above, wherein the conduit includes at least one elasti cally expansible portion which absorbs energy as it expands in response to a pressurized drive fluid therein.
5. The pump control system as set forth inclaim 4 above, wherein the drive fluid is an expandable gas.
6. The pump control system as set forth inclaim 5 above, wherein the drive fluid is compressed air.
7. The pump control system as set forth inclaim 3 above, wherein at least one of said first and second counts isselectively variable under operator control.
8. The pump control system as set forth inclaim 5 above, wherein the electronic digital control circuit includes an oscillator generating a clock signal at a selectively variable frequency; a recycling counter connected to count cycles of the clock signal; means re-. sponsive to the counter for generating first and second intermediate control signals in response to first and second counts'of the counter respectively, said control signal generating means including means for selectively i varying the count at which at least the first intermediate control signal is generated; and means connected to switch the electronic digital control signal to the first and second states in response to the first and second intermediate control signals respectively.
9. A system for providing a selectively controllable pulsatile flow of a perfusate to simulate cardiac action, the flow having selectable diastolic and systolic intervals and pressures comprising:
a pulsatile perfusate pump having at least a pair of pump chamber means responsive to applied fluid pressures;
means providing diastolic and systolic fluid pressures;
conduit means providing substantial impedance to fluid flow and coupling each of said diastolic and systolic pressure means to a different chamber of said perfusate pump;
signal responsive valving means coupled into the conduit means coupling the systolic pressure means to the perfusate pump; and
electronic control signal generating means coupled to said valving means and including means for generating a systole control signal of controllable duration and repetition rates, to provide control signals to said signal responsive valving means, said systole control signal means comprising an electronic digital control circuit which includes an oscillator for generating a clock signal at a selectively variable frequencies; a recycling counter connected to count cycles of the clock signal; means responsive through the counter for generating first and second the first intermediate control signal is generated;
and
means for altering the signal responsive valving means in response to the first and second intermediate control signals respectively.
10. For use in an organ perfusion system circulating a perfusate through an organ, a pulsatile pumping system comprising:
a pump connected to receive perfusate in an inlet and means for connecting the first control fluid inlet to a high pressure control fluid source in response to a first electrical signal condition and disconnecting the first control fluid inlet in response to a second electrical signal condition;
timing control circuit coupled to said means for connecting for providing a bistate electrical signal of selectable periodicity having alternate first and second electrical signal conditions, the control circuit including means responsive to operator control for selecting the relative durations of the first and second electrical signal conditions during each period, in which said timing control circuit comprises an electronic digital control circuit including a recycling counter, means responsive to the counter for assuming the first electrical signal condition when the counter reaches a first selected count, and means responsive to the counter for assuming the second electronic signal condition when the counter reaches a second selected count.
l l l

Claims (10)

1. A system for providing a selectively controllable pulsatile flow of a perfusate to simulate cardiac action comprising: a pulsatile perfusate pump which comprises flexible chamber means, said means being collapsible in response to applied fluid pressure, to pump perfusate in said chamber means through a flow line in pulsatile manner; at least one fluid pressure means; adjustable systolic pressure regulator means coupled to said fluid pressure means; first conduit means including control signal responsive valving means coupling said systolic pressure regulator means to said ventricle chamber means; and electronic control means including adjustable means for generating square wave control signals of adjustable duration and repetition rate, the square waves having sharp rise and fall times, wherein said valving means comprises a two output valve having a venting output and an output communicating with said perfusate pump, wherein said fluid pressure means comprises a pressure storage vessel, and wherein said electronic control means comprises counter means adjustable to provide valving means controlling outputs at selected counts, said counter means being adapted to count said square wave control signals.
3. A combination electronic pneumatic pump control system for gently controlling a pulsatile pump maintaining a first output pressure and producing a periodically occurring systolic output pressure greater than the first pressure in response to a periodically occurring fluid drive pressure comprising: a selectivelY venting pressure control valve having an input connectable to a drive fluid pressure source under control of a transducer; a conduit connected to the outlet of the pressure control valve to a fluid operated pulsatile pump for providing operating fluid to said pump, said conduit restricting the flow of drive fluid therethrough; a transducer connected to control said pressure control valve to selectively connect the outlet to said pressure source in response to first and second states respectively of an electronic digital control signal having sharp transitions between states; and an electronic digital control circuit providing an electronic digital control signal to the transducer, said control circuit including a recycling counter, means responsive to the counter for switching the electronic digital control signal to a first state when the counter reaches a first selected count, and means for switching the electronic digital control signal to a second state when the counter reaches a second selected count, each state being present during a selected variable proportion of each control signal.
9. A system for providing a selectively controllable pulsatile flow of a perfusate to simulate cardiac action, the flow having selectable diastolic and systolic intervals and pressures comprising: a pulsatile perfusate pump having at least a pair of pump chamber means responsive to applied fluid pressures; means providing diastolic and systolic fluid pressures; conduit means providing substantial impedance to fluid flow and coupling each of said diastolic and systolic pressure means to a different chamber of said perfusate pump; signal responsive valving means coupled into the conduit means coupling the systolic pressure means to the perfusate pump; and electronic control signal generating means coupled to said valving means and including means for generating a systole control signal of controllable duration and repetition rates, to provide control signals to said signal responsive valving means, said systole control signal means comprising an electronic digital control circuit which includes an oscillator for generating a clock signal at a selectively variable frequencies; a recycling counter connected to count cycles of the clock signal; means responsive through the counter for generating first and second intermediate control signals in response to the first and second counts of the counter respectively, said control signal generating means including means for selectively varying the count in which at least the first intermediate control signal is generated; and means for altering the signal responsiVe valving means in response to the first and second intermediate control signals respectively.
10. For use in an organ perfusion system circulating a perfusate through an organ, a pulsatile pumping system comprising: a pump connected to receive perfusate in an inlet and deliver perfusate in an outlet, said pump including first and second control fluid inlets and providing a first perfusate pressure at the outlet in response to a high control fluid pressure at the first control fluid inlet and a second perfusate pressure at the outlet in response to a low control fluid pressure at a second control fluid inlet in the absence of the high control fluid pressure at the first control fluid inlet; means for connecting the first control fluid inlet to a high pressure control fluid source in response to a first electrical signal condition and disconnecting the first control fluid inlet in response to a second electrical signal condition; a timing control circuit coupled to said means for connecting for providing a bistate electrical signal of selectable periodicity having alternate first and second electrical signal conditions, the control circuit including means responsive to operator control for selecting the relative durations of the first and second electrical signal conditions during each period, in which said timing control circuit comprises an electronic digital control circuit including a recycling counter, means responsive to the counter for assuming the first electrical signal condition when the counter reaches a first selected count, and means responsive to the counter for assuming the second electronic signal condition when the counter reaches a second selected count.
US361960A1973-05-211973-05-21Pulsatile pumping systemExpired - LifetimeUS3877843A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US361960AUS3877843A (en)1973-05-211973-05-21Pulsatile pumping system

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US361960AUS3877843A (en)1973-05-211973-05-21Pulsatile pumping system

Publications (1)

Publication NumberPublication Date
US3877843Atrue US3877843A (en)1975-04-15

Family

ID=23424111

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US361960AExpired - LifetimeUS3877843A (en)1973-05-211973-05-21Pulsatile pumping system

Country Status (1)

CountryLink
US (1)US3877843A (en)

Cited By (47)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4284073A (en)*1977-10-111981-08-18Krause Horst EMethod and apparatus for pumping blood within a vessel
US4490331A (en)*1982-02-121984-12-25Steg Jr Robert FExtracorporeal blood processing system
US4493697A (en)*1979-05-101985-01-15Krause Horst EMethod and apparatus for pumping blood within a vessel
DE3428828A1 (en)*1984-08-041986-02-13Karl-Theo 6652 Bexbach Braun DEVICE FOR CONVEYING MECHANICAL STRESS HIGH-SENSITIVE LIQUIDS
US4599093A (en)*1982-02-121986-07-08Steg Jr Robert FExtracorporeal blood processing system
US4850954A (en)*1985-09-161989-07-25Guy CharvinConnecting device for an extracorporeal circulation circuit
WO1994006292A1 (en)*1992-09-211994-03-31Bio-Preserve Medical CorporationOrgan perfusion device
US5820579A (en)*1996-04-301998-10-13Medtronic, Inc.Method and apparatus for creating pulsatile flow in a cardiopulmonary bypass circuit
US5965433A (en)*1996-05-291999-10-12Trans D.A.T.A. Service, Inc.Portable perfusion/oxygenation module having mechanically linked dual pumps and mechanically actuated flow control for pulsatile cycling of oxygenated perfusate
WO2000072897A1 (en)*1999-05-272000-12-07East Carolina UniversityPulse wave generator for cardiopulmonary bypass and extracorporeal oxygenation apparatus
DE4407337C2 (en)*1994-03-022003-06-18Gert Baumann Method and device for assessing organ conditions
US6673594B1 (en)1998-09-292004-01-06Organ Recovery SystemsApparatus and method for maintaining and/or restoring viability of organs
WO2003080139A3 (en)*2002-03-262004-03-18Univ LondonDevices for use in medicine
US20040111104A1 (en)*2002-08-232004-06-10Organ Recovery SystemsCannulas, cannula mount assemblies, and clamping methods using such cannulas and cannula mount assemblies
US20040224299A1 (en)*2003-04-042004-11-11Organ Recovery SystemsMethod and apparatus for transferring heat to or from an organ or tissue container
US20040224298A1 (en)*1998-09-292004-11-11John BrassilApparatus and method for determining effects of a substance of an organ
US20040221719A1 (en)*2003-04-042004-11-11Organ Recovery Systems, Inc.Device for separating gas from a liquid path
US20050069426A1 (en)*2002-03-262005-03-31Christopher MasonDevices for use in medicine
US20050255442A1 (en)*2004-05-142005-11-17Organ Recovery SystemsApparatus and method for perfusion and determining the viability of an organ
US20060063142A1 (en)*1998-09-292006-03-23Organ Recovery Systems, Inc.Apparatus and method for maintaining and/or restoring viability of organs
NL1028848C2 (en)*2005-04-222006-10-24Doorzand Airdrive B V Device for transporting an organ.
USD531319S1 (en)2003-04-042006-10-31Organ Recovery SystemsTube frame for organ transporter
USD531320S1 (en)2003-04-042006-10-31Organ Recovery SystemsCassette for organ transporter
US20070184545A1 (en)*2003-07-302007-08-09Plaats Arjan Van DerPortable preservation apparatus for a donor organ
US20070293744A1 (en)*2003-04-162007-12-20Monfre Stephen LApparatus and method for easing use of a spectrophotometric based noninvasive analyzer
US20080288399A1 (en)*2007-05-182008-11-20Lifeline Scientific, Inc.Ex vivo methods for testing organ system disruption
US20080286747A1 (en)*2007-05-182008-11-20Lifeline Scientific, Inc.Ex vivo methods for validating substance testing with human organs and/or tissues
US20110071517A1 (en)*2009-09-232011-03-24Bovie Medical CorporationElectrosurgical system to generate a pulsed plasma stream and method thereof
US20110098624A1 (en)*2001-02-142011-04-28Mccotter CraigMethod and apparatus for treating renal disease with hemodialysis utilizing pulsatile pump
US20110104651A1 (en)*2009-11-042011-05-05Sweeney Terrence EMechanical Model of the Cardiovascular System and Method of Demonstrating the Physiology of the Cardiovascular System
US20120264104A1 (en)*2009-12-112012-10-18Inserm (Institut National De La Sante Et La RecherMethod for the hypothermic perfusion of a cardiac organ, and device for the implementation thereof
US8828034B2 (en)2011-04-292014-09-09Lifeline Scientific, Inc.Cannula
US20140322688A1 (en)*2006-03-032014-10-30EBM CorporationSystem for evaluating cardiac surgery training
US9022978B2 (en)2011-04-292015-05-05Lifeline Scientific, Inc.Universal sealring cannula
US9642625B2 (en)2011-04-292017-05-09Lifeline Scientific, Inc.Cannula for a donor organ with or without an aortic cuff or patch
US9881523B2 (en)2009-11-042018-01-30University Of ScrantonMechanical model of the cardiovascular system and method of demonstrating the physiology of the cardiovascular system
US10176887B1 (en)2005-11-142019-01-08Organ Recovery Systems, Inc.Ex vivo methods for drug discovery, development and testing
EP3427772A1 (en)2017-07-102019-01-16B. Braun Avitum AGOxygenator unit with a pressure relief valve
US10575515B2 (en)2010-05-042020-03-03The General Hospital CorporationMethods and compositions for preserving tissues and organs
US10918102B2 (en)2014-03-132021-02-16The General Hospital CorporationDevices and methods to improve and assess viability of human livers
US20210209969A1 (en)*2018-10-172021-07-08Asahi Intecc Co., Ltd.Human body simulation device, method for controlling human body simulation device, and computer program
US11136553B2 (en)2009-07-012021-10-05Massachusetts Institute Of TechnologyIsolated adult cells, artificial organs, rehabilitated organs, research tools, organ encasements, organ perfusion systems, and methods for preparing and utilizing the same
US11189196B2 (en)*2014-04-242021-11-30Colorado State University Research FoundationSystems and methods for palpation training
US20230067043A1 (en)*2021-08-252023-03-02The First Affiliated Hospital, Sun Yat-Sen UniversityMulti-organ repairing and transferring device without interrupting blood flow
US12029889B2 (en)2022-04-012024-07-09Tulyp Medical SasPerfusion systems and methods for monitoring tissue oxygenation and reducing limb ischemia
US12058996B2 (en)2017-06-142024-08-13The General Hospital CorporationHigh subzero cryopreservation
US12167729B2 (en)2018-05-302024-12-17The General Hospital CorporationCryopreservation of tissues and organs

Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3266487A (en)*1963-06-041966-08-16Sundstrand CorpHeart pump augmentation system and apparatus
US3376660A (en)*1965-07-121968-04-09Westinghouse Electric CorpCirculatory system simulator
US3430624A (en)*1966-09-071969-03-04United Aircraft CorpDelay time computer for heart pump system
US3516331A (en)*1967-03-211970-06-23Chandler Evans IncTime modulated hydraulically actuated control mechanism
US3545221A (en)*1967-05-221970-12-08Swenko Research & Dev IncApparatus for maintaining organs in vitro in a completely viable state
US3639084A (en)*1970-04-061972-02-01Baxter Laboratories IncMechanism for control pulsatile fluid flow

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3266487A (en)*1963-06-041966-08-16Sundstrand CorpHeart pump augmentation system and apparatus
US3376660A (en)*1965-07-121968-04-09Westinghouse Electric CorpCirculatory system simulator
US3430624A (en)*1966-09-071969-03-04United Aircraft CorpDelay time computer for heart pump system
US3516331A (en)*1967-03-211970-06-23Chandler Evans IncTime modulated hydraulically actuated control mechanism
US3545221A (en)*1967-05-221970-12-08Swenko Research & Dev IncApparatus for maintaining organs in vitro in a completely viable state
US3639084A (en)*1970-04-061972-02-01Baxter Laboratories IncMechanism for control pulsatile fluid flow

Cited By (95)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4284073A (en)*1977-10-111981-08-18Krause Horst EMethod and apparatus for pumping blood within a vessel
US4493697A (en)*1979-05-101985-01-15Krause Horst EMethod and apparatus for pumping blood within a vessel
US4490331A (en)*1982-02-121984-12-25Steg Jr Robert FExtracorporeal blood processing system
US4599093A (en)*1982-02-121986-07-08Steg Jr Robert FExtracorporeal blood processing system
DE3428828A1 (en)*1984-08-041986-02-13Karl-Theo 6652 Bexbach Braun DEVICE FOR CONVEYING MECHANICAL STRESS HIGH-SENSITIVE LIQUIDS
US4850954A (en)*1985-09-161989-07-25Guy CharvinConnecting device for an extracorporeal circulation circuit
WO1994006292A1 (en)*1992-09-211994-03-31Bio-Preserve Medical CorporationOrgan perfusion device
US5338662A (en)*1992-09-211994-08-16Bio-Preserve Medical CorporationOrgan perfusion device
US5494822A (en)*1992-09-211996-02-27Bio-Preserve Medical CorporationOrgan perfusion device
DE4407337C2 (en)*1994-03-022003-06-18Gert Baumann Method and device for assessing organ conditions
US5820579A (en)*1996-04-301998-10-13Medtronic, Inc.Method and apparatus for creating pulsatile flow in a cardiopulmonary bypass circuit
US5965433A (en)*1996-05-291999-10-12Trans D.A.T.A. Service, Inc.Portable perfusion/oxygenation module having mechanically linked dual pumps and mechanically actuated flow control for pulsatile cycling of oxygenated perfusate
US20040224298A1 (en)*1998-09-292004-11-11John BrassilApparatus and method for determining effects of a substance of an organ
US8445260B2 (en)1998-09-292013-05-21Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US6673594B1 (en)1998-09-292004-01-06Organ Recovery SystemsApparatus and method for maintaining and/or restoring viability of organs
US7749693B2 (en)1998-09-292010-07-06Lifeline Scientific, Inc.Method of determining that an organ is not suitable for transplantation and using it for testing substances
US7824848B2 (en)1998-09-292010-11-02Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8962303B2 (en)1998-09-292015-02-24Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US20100221696A1 (en)*1998-09-292010-09-02Organ Recovery Systems, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8609400B2 (en)1998-09-292013-12-17Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US20110059429A1 (en)*1998-09-292011-03-10Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8268612B2 (en)1998-09-292012-09-18Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US20060063142A1 (en)*1998-09-292006-03-23Organ Recovery Systems, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8431385B2 (en)1998-09-292013-04-30Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8420381B2 (en)1998-09-292013-04-16Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US20110129908A1 (en)*1998-09-292011-06-02Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8349551B2 (en)1998-09-292013-01-08Lifeline Scientific, Inc.Method for controlling perfusion of an organ
US8268547B2 (en)1998-09-292012-09-18Lifeline Scientific, Inc.Method of transporting and storing a kidney
US8318415B2 (en)1998-09-292012-11-27Lifeline Scientific, Inc.Method of determining transport and/or storage parameters for maintaining viability of an organ
WO2000072897A1 (en)*1999-05-272000-12-07East Carolina UniversityPulse wave generator for cardiopulmonary bypass and extracorporeal oxygenation apparatus
US6620121B1 (en)1999-05-272003-09-16East Carolina UniversityPulse wave generator for cardiopulmonary bypass and extracorporeal oxygenation apparatus
US8323954B2 (en)2000-08-252012-12-04Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US20110098624A1 (en)*2001-02-142011-04-28Mccotter CraigMethod and apparatus for treating renal disease with hemodialysis utilizing pulsatile pump
US20050069426A1 (en)*2002-03-262005-03-31Christopher MasonDevices for use in medicine
WO2003080139A3 (en)*2002-03-262004-03-18Univ LondonDevices for use in medicine
US8361091B2 (en)2002-08-232013-01-29Organ Recovery Systems, Inc.Cannulas, cannula mount assemblies, and clamping methods using such cannulas and cannula mount assemblies
US20040111104A1 (en)*2002-08-232004-06-10Organ Recovery SystemsCannulas, cannula mount assemblies, and clamping methods using such cannulas and cannula mount assemblies
US8097449B2 (en)2003-04-042012-01-17Organ Recovery SystemsMethod and apparatus for transferring heat to or from an organ or tissue container
US7678563B2 (en)2003-04-042010-03-16Organ Recovery Systems, Inc.Method and apparatus for controlling air pressure in an organ or tissue container
US20100151559A1 (en)*2003-04-042010-06-17Lifeline Scientific, Inc.Method and apparatus for transferring heat to or from an organ or tissue container
US20100112542A1 (en)*2003-04-042010-05-06Organ Recovery Systems, Inc.Method and apparatus for controlling air pressure in an organ or tissue container
US20040224299A1 (en)*2003-04-042004-11-11Organ Recovery SystemsMethod and apparatus for transferring heat to or from an organ or tissue container
US7691622B2 (en)2003-04-042010-04-06Lifeline Scientific, Inc.Method and apparatus for transferring heat to or from an organ or tissue container
USD531320S1 (en)2003-04-042006-10-31Organ Recovery SystemsCassette for organ transporter
US8389271B2 (en)2003-04-042013-03-05Organ Recovery Systems, Inc.Method and apparatus for controlling air pressure in an organ or tissue container
US7998725B2 (en)2003-04-042011-08-16Organ Recovery SystemsMethod and apparatus for holding a plurality of tubes connectible to an organ or tissue container
US20040221719A1 (en)*2003-04-042004-11-11Organ Recovery Systems, Inc.Device for separating gas from a liquid path
US8128740B2 (en)2003-04-042012-03-06Organ Recovery Systems, Inc.Device for separating gas from a liquid path
USD531319S1 (en)2003-04-042006-10-31Organ Recovery SystemsTube frame for organ transporter
US20070293744A1 (en)*2003-04-162007-12-20Monfre Stephen LApparatus and method for easing use of a spectrophotometric based noninvasive analyzer
US7811808B2 (en)2003-07-302010-10-12Organ Assist B.V.Portable preservation apparatus for a donor organ
US20070184545A1 (en)*2003-07-302007-08-09Plaats Arjan Van DerPortable preservation apparatus for a donor organ
US8741555B2 (en)2004-05-142014-06-03Organ Recovery Systems, Inc.Apparatus and method for perfusion and determining the viability of an organ
US20050255442A1 (en)*2004-05-142005-11-17Organ Recovery SystemsApparatus and method for perfusion and determining the viability of an organ
US8993225B2 (en)2005-04-222015-03-31Oxiplenish B.V.Device for transporting an organ
WO2006112720A3 (en)*2005-04-222006-12-14Doorzand Airdrive B VDevice for transporting an organ
CN102640743B (en)*2005-04-222014-10-15多尔灿德气动股份有限公司Device for transporting organ
CN102640743A (en)*2005-04-222012-08-22多尔灿德气动股份有限公司Device for transporting organ
CN101198251B (en)*2005-04-222012-06-06多尔灿德气动股份有限公司Device for transporting an organ
NL1028848C2 (en)*2005-04-222006-10-24Doorzand Airdrive B V Device for transporting an organ.
US20100015592A1 (en)*2005-04-222010-01-21Doorzand Airdrive B.V.Device for transporting an organ
US10176887B1 (en)2005-11-142019-01-08Organ Recovery Systems, Inc.Ex vivo methods for drug discovery, development and testing
US20140322688A1 (en)*2006-03-032014-10-30EBM CorporationSystem for evaluating cardiac surgery training
US8765364B2 (en)2007-05-182014-07-01Lifeline Scientific, Inc.Ex vivo methods for validating substance testing with human organs and/or tissues
US8771930B2 (en)2007-05-182014-07-08Lifeline Scientific, Inc.Ex vivo methods for testing toxicity of substances using donated human organs or tissues
US20080286747A1 (en)*2007-05-182008-11-20Lifeline Scientific, Inc.Ex vivo methods for validating substance testing with human organs and/or tissues
US20080288399A1 (en)*2007-05-182008-11-20Lifeline Scientific, Inc.Ex vivo methods for testing organ system disruption
US11136553B2 (en)2009-07-012021-10-05Massachusetts Institute Of TechnologyIsolated adult cells, artificial organs, rehabilitated organs, research tools, organ encasements, organ perfusion systems, and methods for preparing and utilizing the same
US9649143B2 (en)*2009-09-232017-05-16Bovie Medical CorporationElectrosurgical system to generate a pulsed plasma stream and method thereof
US20110071517A1 (en)*2009-09-232011-03-24Bovie Medical CorporationElectrosurgical system to generate a pulsed plasma stream and method thereof
US20110104651A1 (en)*2009-11-042011-05-05Sweeney Terrence EMechanical Model of the Cardiovascular System and Method of Demonstrating the Physiology of the Cardiovascular System
US9881523B2 (en)2009-11-042018-01-30University Of ScrantonMechanical model of the cardiovascular system and method of demonstrating the physiology of the cardiovascular system
US9576504B2 (en)*2009-11-042017-02-21University Of ScrantonMechanical model of the cardiovascular system and method of demonstrating the physiology of the cardiovascular system
US8802425B2 (en)*2009-12-112014-08-12Universite Claude Bernard Lyon IMethod for the hypothermic perfusion of a cardiac organ, and device for the implementation thereof
US20120264104A1 (en)*2009-12-112012-10-18Inserm (Institut National De La Sante Et La RecherMethod for the hypothermic perfusion of a cardiac organ, and device for the implementation thereof
US10575515B2 (en)2010-05-042020-03-03The General Hospital CorporationMethods and compositions for preserving tissues and organs
US12239126B2 (en)2010-05-042025-03-04The General Hospital CorporationMethods and compositions for preserving tissues and organs
US9022978B2 (en)2011-04-292015-05-05Lifeline Scientific, Inc.Universal sealring cannula
US8828034B2 (en)2011-04-292014-09-09Lifeline Scientific, Inc.Cannula
US9642625B2 (en)2011-04-292017-05-09Lifeline Scientific, Inc.Cannula for a donor organ with or without an aortic cuff or patch
US11917992B2 (en)2014-03-132024-03-05The General Hospital CorporationDevices and methods to improve and assess viability of human livers
US12329150B2 (en)2014-03-132025-06-17The General Hospital CorporationDevices and methods to improve and assess viability of human livers
US10918102B2 (en)2014-03-132021-02-16The General Hospital CorporationDevices and methods to improve and assess viability of human livers
US11189196B2 (en)*2014-04-242021-11-30Colorado State University Research FoundationSystems and methods for palpation training
US12058996B2 (en)2017-06-142024-08-13The General Hospital CorporationHigh subzero cryopreservation
US12042588B2 (en)2017-07-102024-07-23B. Braun Avitum AgOxygenator unit with a pressure relief valve
US11013842B2 (en)2017-07-102021-05-25B. Braun Avitum AgOxygenator unit with a pressure relief valve
EP3427772A1 (en)2017-07-102019-01-16B. Braun Avitum AGOxygenator unit with a pressure relief valve
US12167729B2 (en)2018-05-302024-12-17The General Hospital CorporationCryopreservation of tissues and organs
US11908342B2 (en)*2018-10-172024-02-20Asahi Intecc Co., Ltd.Human body simulation device, method for controlling human body simulation device, and computer program
US20210209969A1 (en)*2018-10-172021-07-08Asahi Intecc Co., Ltd.Human body simulation device, method for controlling human body simulation device, and computer program
US11617364B2 (en)*2021-08-252023-04-04The First Affiliated Hospital, Sun Yat-Sen UniversityMulti-organ repairing and transferring device without interrupting blood flow
US20230067043A1 (en)*2021-08-252023-03-02The First Affiliated Hospital, Sun Yat-Sen UniversityMulti-organ repairing and transferring device without interrupting blood flow
US12029889B2 (en)2022-04-012024-07-09Tulyp Medical SasPerfusion systems and methods for monitoring tissue oxygenation and reducing limb ischemia
US12364852B2 (en)2022-04-012025-07-22Tulyp Medical SasPerfusion systems and methods for monitoring tissue oxygenation and reducing limb ischemia

Similar Documents

PublicationPublication DateTitle
US3877843A (en)Pulsatile pumping system
US3639084A (en)Mechanism for control pulsatile fluid flow
US3892628A (en)Preservation of organs
US5326706A (en)Homeostatic organ preservation system
US2925814A (en)Transfusion apparatus
US3298320A (en)Atraumatic fluid pump
US3568214A (en)Artificial heart system and method of pumping blood by electromagnetically pulsed fluid
US4432468A (en)Intravenous delivery system
TR23305A (en) POSITIVE TRANSFER DIAPHRAGM PUMPS FROM TRANSFER VALVES
US3183908A (en)Pump oxygenator system
JPS60225570A (en) blood pump
BRPI0410314B1 (en) AIR PRESSURE POWERED DRIVER FOR PNEUMATIC VENTRICULAR AUXILIARY DEVICES
Barila et al.A blood pump powered and controlled by a fluid amplification system
Kabei et al.A portable pneumatic driving unit for a left ventricular assist device
US3337878A (en)Artificial heart cycling system
CN111298287B (en)Bionic ECMO equipment for external life support
Sakamoto et al.Changes of intraaortic balloon volume during pumping in a mock circulation system
Kaufmann et al.The implantable fuzzy controlled Helmholtz‐left ventricular assist device: first in vitro testing
Nabel et al.Relationship between design and control of artificial heart for protection of the right/left balance
WoodwardCaptain Daniel E. Nunn (MC.)(2)
CN114005345B (en)Medical care end of pulse diagnosis instrument
SU736980A1 (en)Control system of perfusion membrane pump
Isoyama et al.Flow-transformed pulsatile total artificial heart (FTPTAH) with no electrical switching valve
Kimoto et al.Studies on the artificial heart driven with controlled gas pressure device on the pressure generator for universal use
BolieA pneumatic pressure cycling system for an artificial heart

[8]ページ先頭

©2009-2025 Movatter.jp